Extracellular Vesicle Cargo from Lipofibroblasts Mitigates COPD by Alveolar Type II Cell Restoration
Our findings highlight the therapeutic potential of LipoFB-EVs as a novel regenerative therapy for COPD, offering promising avenues for future clinical interventions.
Authors
- Pattama WIRIYASERMKUL
- Takashi Ohtsuka
- Hiromichi Hara (ORCID: https://orcid.org/0000-0001-9507-7454)
- Kazuki Kawajiri
- Saiko Nishioka
- Shunsuke Minagawa (ORCID: https://orcid.org/0000-0003-1732-4856)
- Shun Inukai
- Yuta Hirano
- K Kuwano
- Yu Fujita (ORCID: https://orcid.org/0000-0002-8916-7303)
- Shushi Nagamori
- Naoaki Watanabe
- Masahiro Yoshida
- Saburo Ito
- Shota Fujimoto
- Jun Araya
- Sachi Matsubayashi
Institutions
- Jikei University School of Medicine (JP)
- Iwate University (JP)
Publication Details
- Journal
- American Journal of Respiratory and Critical Care Medicine
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1093/ajrccm/aamag025
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00